Epigenetics of colorectal cancer

Gastroenterology

Volumn 143, Issue 6, 2012, Pages

  Goel, Ajay ^a   Boland, C Richard ^a  

^a BAYLOR RESEARCH INSTITUTE   (United States)

Author keywords

DNA Methylation; Genomic Instability; Histone Modifications; microRNA

Indexed keywords

AZACITIDINE; BIOLOGICAL MARKER; BOSWELLIC ACID; CAPECITABINE; CURCUMIN; FLUOROURACIL; HISTONE DEACETYLASE INHIBITOR; MICRORNA; POLYCOMB GROUP PROTEIN; PROTEIN MSH2; VALPROIC ACID; VORINOSTAT;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER CHEMOTHERAPY; CARCINOGENESIS; CLINICAL TRIAL; COLORECTAL CANCER; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HISTONE MODIFICATION; HUMAN; ONCOGENE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

EID: 84869808619     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.09.032     Document Type: Review

References (199)

1. M. Gardiner-Garden, M. Frommer CpG islands in vertebrate genomes J Mol Biol 196 1987 261 282
2. V.V. Lao, W.M. Grady Epigenetics and colorectal cancer Nat Rev Gastroenterol Hepatol 8 2011 686 700
3. J.R. Graff, J.G. Herman, S. Myohanen Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation J Biol Chem 272 1997 22322 22329
4. S.L. Ooi, S. Henikoff Germline histone dynamics and epigenetics Curr Opin Cell Biol 19 2007 257 265
5. B.P. Chadwick, H.F. Willard Chromatin of the Barr body: histone and non-histone proteins associated with or excluded from the inactive X chromosome Hum Mol Genet 12 2003 2167 2178
6. A.P. Feinberg, B. Vogelstein Hypomethylation distinguishes genes of some human cancers from their normal counterparts Nature 301 1983 89 92
7. S.E. Goelz, B. Vogelstein, S.R. Hamilton Hypomethylation of DNA from benign and malignant human colon neoplasms Science 228 1985 187 190
8. A.P. Feinberg, C.W. Gehrke, K.C. Kuo Reduced genomic 5-methylcytosine content in human colonic neoplasia Cancer Res 48 1988 1159 1161
9. S.B. Baylin, B.A. Hoppener JW de, P.H. Steenbergh DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas Cancer Res 46 1986 2917 2922
10. J.P. Issa, Y.L. Ottaviano, P. Celano Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon Nat Genet 7 1994 536 540
11. J.P. Issa, P.M. Vertino, C.D. Boehm Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis Proc Natl Acad Sci U S A 93 1996 11757 11762
12. J.G. Herman, C.I. Civin, J.P. Issa Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies Cancer Res 57 1997 837 841
13. N. Ahuja, Q. Li, A.L. Mohan Aging and DNA methylation in colorectal mucosa and cancer Cancer Res 58 1998 5489 5494
14. M. Toyota, N. Ahuja, M. Ohe-Toyota CpG island methylator phenotype in colorectal cancer Proc Natl Acad Sci U S A 96 1999 8681 8686
15. A. Goel, C.N. Arnold, P. Tassone Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers Int J Cancer 112 2004 754 759
16. A. Goel, C.N. Arnold, D. Niedzwiecki Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers Cancer Res 64 2004 3014 3021
17. S.K. Shin, T. Nagasaka, B.H. Jung Epigenetic and genetic alterations in Netrin-1 receptors UNC5C and DCC in human colon cancer Gastroenterology 133 2007 1849 1857
18. A. Rashid, J.P. Issa CpG island methylation in gastroenterologic neoplasia: a maturing field Gastroenterology 127 2004 1578 1588
19. D.L. Worthley, V.L. Whitehall, R.L. Buttenshaw DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer Oncogene 29 2010 1653 1662
20. N. Ahuja, J.P. Issa Aging, methylation and cancer Histol Histopathol 15 2000 835 842
21. D.J. Weisenberger, K.D. Siegmund, M. Campan CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer Nat Genet 38 2006 787 793
22. K.J. Spring, Z.Z. Zhao, R. Karamatic High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy Gastroenterology 131 2006 1400 1407
23. T. Nagasaka, M. Koi, M. Kloor Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer Gastroenterology 134 2008 1950 1960
24. M.J. O'Brien, S. Yang, C. Mack Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points Am J Surg Pathol 30 2006 1491 1501
25. B. Leggett, V. Whitehall Role of the serrated pathway in colorectal cancer pathogenesis Gastroenterology 138 2010 2088 2100
26. W.S. Samowitz, H. Albertsen, J. Herrick Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer Gastroenterology 129 2005 837 845
27. W.S. Samowitz, H. Albertsen, C. Sweeney Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer J Natl Cancer Inst 98 2006 1731 1738
28. L. Shen, P.J. Catalano, A.B. Benson III Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy Clin Cancer Res 13 2007 6093 6098
29. S. Ogino, K. Nosho, G.J. Kirkner CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer Gut 58 2009 90 96
30. C.N. Arnold, A. Goel, C.R. Boland Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines Int J Cancer 106 2003 66 73
31. C.M. Ribic, D.J. Sargent, M.J. Moore Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer N Engl J Med 349 2003 247 257
32. J.M. Carethers, E.J. Smith, C.A. Behling Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer Gastroenterology 126 2004 394 401
33. R. Jover, T.P. Nguyen, L. Perez-Carbonell 5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer Gastroenterology 140 2011 1174 1181
34. A. Goel, C.N. Arnold, D. Niedzwiecki Characterization of sporadic colon cancer by patterns of genomic instability Cancer Res 63 2003 1608 1614
35. A. Goel, T. Nagasaka, C.N. Arnold The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer Gastroenterology 132 2007 127 138
36. C.N. Arnold, A. Goel, D. Niedzwiecki APC promoter hypermethylation contributes to the loss of APC expression in colorectal cancers with allelic loss on 5q Cancer Biol Ther 3 2004 960 964
37. C.N. Arnold, A. Goel, C. Compton Evaluation of microsatellite instability, hMLH1 expression and hMLH1 promoter hypermethylation in defining the MSI phenotype of colorectal cancer Cancer Biol Ther 3 2004 73 78
38. T. Nagasaka, A. Goel, K. Notohara Methylation pattern of the O6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesis Int J Cancer 122 2008 2429 2436
39. C.R. Boland, A. Goel Microsatellite instability in colorectal cancer Gastroenterology 138 2010 2073 2087
40. M.F. Kane, M. Loda, G.M. Gaida Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines Cancer Res 57 1997 808 811
41. J.P. Issa CpG island methylator phenotype in cancer Nat Rev Cancer 4 2004 988 993
42. T.L. Chan, S.T. Yuen, C.K. Kong Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer Nat Genet 38 2006 1178 1183
43. M.J. Ligtenberg, R.P. Kuiper, T.L. Chan Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1 Nat Genet 41 2009 112 117
44. H.T. Lynch, D.L. Riegert-Johnson, C. Snyder Lynch syndrome-associated extracolonic tumors are rare in two extended families with the same EPCAM deletion Am J Gastroenterol 106 2011 1829 1836
45. T. Nagasaka, J. Rhees, M. Kloor, J. Gebert Somatic hypermethylation of MSH2 is a frequent event in Lynch Syndrome colorectal cancers Cancer Res 70 2010 3098 3108
46. M.L. Frazier, L. Xi, J. Zong Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer Cancer Res 63 2003 4805 4808
47. I. Gazzoli, M. Loda, J. Garber A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor Cancer Res 62 2002 3925 3928
48. M. Hitchins, R. Williams, K. Cheong MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer Gastroenterology 129 2005 1392 1399
49. M.P. Hitchins, J.J. Wong, G. Suthers Inheritance of a cancer-associated MLH1 germ-line epimutation N Engl J Med 356 2007 697 705
50. M.P. Hitchins, R.W. Rapkins, C.T. Kwok Dominantly inherited constitutional epigenetic silencing of MLH1 in a cancer-affected family is linked to a single nucleotide variant within the 5′UTR Cancer Cell 20 2011 200 213
51. A. Goel, T.P. Nguyen, H.C. Leung De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one Int J Cancer 128 2011 869 878
52. S. Ogino, A. Goel Molecular classification and correlates in colorectal cancer J Mol Diagn 10 2008 13 27
53. S. Ogino, M. Cantor, T. Kawasaki CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies Gut 55 2006 1000 1006
54. L.A. Herrera, D. Prada, M.A. Andonegui The epigenetic origin of aneuploidy Curr Genomics 9 2008 43 50
55. A. Silver, N. Sengupta, D. Propper A distinct DNA methylation profile associated with microsatellite and chromosomal stable sporadic colorectal cancers Int J Cancer 130 2012 1082 1092
56. A. Goel, R.M. Xicola, T.P. Nguyen Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency Gastroenterology 138 2010 1854 1862
57. T. Kouzarides Chromatin modifications and their function Cell 128 2007 693 705
58. L.A. Mathews, F. Crea, W.L. Farrar Epigenetic gene regulation in stem cells and correlation to cancer Differentiation 78 2009 1 17
59. A.J. Bannister, T. Kouzarides Regulation of chromatin by histone modifications Cell Res 21 2011 381 395
60. P.A. Jones, S.B. Baylin The epigenomics of cancer Cell 128 2007 683 692
61. A. Sparmann, M. van Lohuizen Polycomb silencers control cell fate, development and cancer Nat Rev Cancer 6 2006 846 856
62. J.A. Simon, R.E. Kingston Mechanisms of polycomb gene silencing: knowns and unknowns Nat Rev Mol Cell Biol 10 2009 697 708
63. J.E. Ohm, K.M. McGarvey, X. Yu A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing Nat Genet 39 2007 237 242
64. E. Vire, C. Brenner, R. Deplus The Polycomb group protein EZH2 directly controls DNA methylation Nature 439 2006 871 874
65. H.P. Mohammad, Y. Cai, K.M. McGarvey Polycomb CBX7 promotes initiation of heritable repression of genes frequently silenced with cancer-specific DNA hypermethylation Cancer Res 69 2009 6322 6330
66. B. Jin, B. Yao, J.L. Li DNMT1 and DNMT3B modulate distinct polycomb-mediated histone modifications in colon cancer Cancer Res 69 2009 7412 7421
67. O. Fluge, K. Gravdal, E. Carlsen Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis Br J Cancer 101 2009 1282 1289
68. C.G. Wang, Y.J. Ye, J. Yuan EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis World J Gastroenterol 16 2010 2421 2427
69. B. Fussbroich, N. Wagener, S. Macher-Goeppinger EZH2 depletion blocks the proliferation of colon cancer cells PLoS One 6 2011 e21651
70. A. Viel, R. Maestro, G. Toffoli c-myc overexpression is a tumor-specific phenomenon in a subset of human colorectal carcinomas J Cancer Res Clin Oncol 116 1990 288 294
71. J.A. Fahrner, S. Eguchi, J.G. Herman Dependence of histone modifications and gene expression on DNA hypermethylation in cancer Cancer Res 62 2002 7213 7218
72. K.E. Bachman, B.H. Park, I. Rhee Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene Cancer Cell 3 2003 89 95
73. J. Si, Y.A. Boumber, J. Shu Chromatin remodeling is required for gene reactivation after decitabine-mediated DNA hypomethylation Cancer Res 70 2010 6968 6977
74. W. Weichert, A. Roske, S. Niesporek Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo Clin Cancer Res 14 2008 1669 1677
75. H. Ashktorab, K. Belgrave, F. Hosseinkhah Global histone H4 acetylation and HDAC2 expression in colon adenoma and carcinoma Dig Dis Sci 54 2009 2109 2117
76. K. Ishihama, M. Yamakawa, S. Semba Expression of HDAC1 and CBP/p300 in human colorectal carcinomas J Clin Pathol 60 2007 1205 1210
77. K. Nosho, K. Shima, N. Irahara SIRT1 histone deacetylase expression is associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer Mod Pathol 22 2009 922 932
78. O. Slaby, M. Svoboda, J. Michalek MicroRNAs in colorectal cancer: translation of molecular biology into clinical application Mol Cancer 8 2009 102
79. S. Griffiths-Jones, H.K. Saini, S. van Dongen miRBase: tools for microRNA genomics Nucleic Acids Res 36 2008 D154 D158
80. G.A. Calin, C.D. Dumitru, M. Shimizu Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia Proc Natl Acad Sci U S A 99 2002 15524 15529
81. R. Garzon, G.A. Calin, C.M. Croce MicroRNAs in cancer Annu Rev Med 60 2009 167 179
82. B.P. Lewis, C.B. Burge, D.P. Bartel Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Cell 120 2005 15 20
83. J. Lu, G. Getz, E.A. Miska MicroRNA expression profiles classify human cancers Nature 435 2005 834 838
84. S. Volinia, G.A. Calin, C.G. Liu A microRNA expression signature of human solid tumors defines cancer gene targets Proc Natl Acad Sci U S A 103 2006 2257 2261
85. M.Z. Michael, S.M. O' Connor, N.G. van Holst Pellekaan Reduced accumulation of specific microRNAs in colorectal neoplasia Mol Cancer Res 1 2003 882 891
86. J.M. Cummins, Y. He, R.J. Leary The colorectal microRNAome Proc Natl Acad Sci U S A 103 2006 3687 3692
87. E. Bandres, E. Cubedo, X. Agirre Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues Mol Cancer 5 2006 29
88. T. Schepeler, J.T. Reinert, M.S. Ostenfeld Diagnostic and prognostic microRNAs in stage II colon cancer Cancer Res 68 2008 6416 6424
89. C.J. Wang, Z.G. Zhou, L. Wang Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer Dis Markers 26 2009 27 34
90. A.J. Schetter, S.Y. Leung, J.J. Sohn MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma JAMA 299 2008 425 436
91. K. Motoyama, H. Inoue, Y. Takatsuno Over- and under-expressed microRNAs in human colorectal cancer Int J Oncol 34 2009 1069 1075
92. O. Slaby, M. Svoboda, P. Fabian Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer Oncology 72 2007 397 402
93. G. Lanza, M. Ferracin, R. Gafa mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer Mol Cancer 6 2007 54
94. A.L. Sarver, A.J. French, P.M. Borralho Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states BMC Cancer 9 2009 401
95. F. Balaguer, L. Moreira, J.J. Lozano Colorectal cancers with microsatellite instability display unique miRNA profiles Clin Cancer Res 17 2011 6239 6249
96. E. Bandres, X. Agirre, N. Bitarte Epigenetic regulation of microRNA expression in colorectal cancer Int J Cancer 125 2009 2737 2743
97. M. Toyota, H. Suzuki, Y. Sasaki Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer Cancer Res 68 2008 4123 4132
98. M. Vogt, J. Munding, M. Gruner Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas Virchows Arch 458 2011 313 322
99. H. Suzuki, S. Takatsuka, H. Akashi Genome-wide profiling of chromatin signatures reveals epigenetic regulation of MicroRNA genes in colorectal cancer Cancer Res 71 2011 5646 5658
100. W.M. Grady, R.K. Parkin, P.S. Mitchell Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer Oncogene 27 2008 3880 3888
101. F. Balaguer, A. Link, J.J. Lozano Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis Cancer Res 70 2010 6609 6618
102. D.J. Papachristou, A. Korpetinou, E. Giannopoulou Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas Virchows Arch 459 2011 431 440
103. C. Faber, D. Horst, F. Hlubek Overexpression of Dicer predicts poor survival in colorectal cancer Eur J Cancer 47 2011 1414 1419
104. J. Stratmann, C.J. Wang, S. Gnosa Dicer and miRNA in relation to clinicopathological variables in colorectal cancer patients BMC Cancer 11 2011 345
105. E.R. Fearon, B. Vogelstein A genetic model for colorectal tumorigenesis Cell 61 1990 759 767
106. R. Nagel, C. le Sage, B. Diosdado Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer Cancer Res 68 2008 5795 5802
107. G.M. Arndt, L. Dossey, L.M. Cullen Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer BMC Cancer 9 2009 374
108. M. Monzo, A. Navarro, E. Bandres Overlapping expression of microRNAs in human embryonic colon and colorectal cancer Cell Res 18 2008 823 833
109. A.L. Oberg, A.J. French, A.L. Sarver miRNA expression in colon polyps provides evidence for a multihit model of colon cancer PLoS One 6 2011 e20465
110. J.S. Earle, R. Luthra, A. Romans Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma J Mol Diagn 12 2010 433 440
111. W.P. Tsang, E.K. Ng, S.S. Ng Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer Carcinogenesis 31 2010 350 358
112. H. Cheng, L. Zhang, D.E. Cogdell Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis PLoS One 6 2011 e17745
113. K.J. Schmitz, S. Hey, A. Schinwald Differential expression of microRNA 181b and microRNA 21 in hyperplastic polyps and sessile serrated adenomas of the colon Virchows Arch 455 2009 49 54
114. N. Yamamichi, R. Shimomura, K. Inada Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development Clin Cancer Res 15 2009 4009 4016
115. M.S. Kumar, J. Lu, K.L. Mercer Impaired microRNA processing enhances cellular transformation and tumorigenesis Nat Genet 39 2007 673 677
116. R.G. La, M. Badin, B. Shi Mechanism of growth inhibition by MicroRNA 145: the role of the IGF-I receptor signaling pathway J Cell Physiol 220 2009 485 491
117. H.I. Suzuki, K. Yamagata, K. Sugimoto Modulation of microRNA processing by p53 Nature 460 2009 529 533
118. Y. Akao, Y. Nakagawa, T. Naoe MicroRNA-143 and -145 in colon cancer DNA Cell Biol 26 2007 311 320
119. M. Sachdeva, S. Zhu, F. Wu p53 represses c-Myc through induction of the tumor suppressor miR-145 Proc Natl Acad Sci U S A 106 2009 3207 3212
120. L.H. Gregersen, A.B. Jacobsen, L.B. Frankel MicroRNA-145 targets YES and STAT1 in colon cancer cells PLoS One 5 2010 e8836
121. N. Xu, T. Papagiannakopoulos, G. Pan MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells Cell 137 2009 647 658
122. X. Chen, X. Guo, H. Zhang Role of miR-143 targeting KRAS in colorectal tumorigenesis Oncogene 28 2009 1385 1392
123. E.K. Ng, W.P. Tsang, S.S. Ng MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer Br J Cancer 101 2009 699 706
124. H. Zhang, Y. Li, M. Lai The microRNA network and tumor metastasis Oncogene 29 2010 937 948
125. P.A. Gregory, A.G. Bert, E.L. Paterson The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 Nat Cell Biol 10 2008 593 601
126. L. Wang, J.M. Cunningham, J.L. Winters BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair Cancer Res 63 2003 5209 5212
127. W.M. Grady, A. Rajput, J.D. Lutterbaugh Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer Cancer Res 61 2001 900 902
128. H. Zou, B. Yu, R. Zhao Detection of aberrant p16 methylation in the serum of colorectal cancer patients Zhonghua Yu Fang Yi Xue Za Zhi 36 2002 499 501
129. H. Nakayama, K. Hibi, T. Takase Molecular detection of p16 promoter methylation in the serum of recurrent colorectal cancer patients Int J Cancer 105 2003 491 493
130. G. Nakayama, K. Hibi, H. Nakayama A highly sensitive method for the detection of p16 methylation in the serum of colorectal cancer patients Anticancer Res 27 2007 1459 1463
131. S. Yamaguchi, T. Asao, J. Nakamura High frequency of DAP-kinase gene promoter methylation in colorectal cancer specimens and its identification in serum Cancer Lett 194 2003 99 105
132. S.H. Tan, H. Ida, Q.C. Lau Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3 Oncol Rep 18 2007 1225 1230
133. M.P. Ebert, F. Model, S. Mooney Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas Gastroenterology 131 2006 1418 1430
134. C. Lofton-Day, F. Model, T. deVos DNA methylation biomarkers for blood-based colorectal cancer screening Clin Chem 54 2008 414 423
135. T. deVos, R. Tetzner, F. Model Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer Clin Chem 55 2009 1337 1346
136. R. Grutzmann, B. Molnar, C. Pilarsky Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay PLoS One 3 2008 e3759
137. W.D. Chen, Z.J. Han, J. Skoletsky Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene J Natl Cancer Inst 97 2005 1124 1132
138. T. Nagasaka, N. Tanaka, H.M. Cullings Analysis of fecal DNA methylation to detect gastrointestinal neoplasia J Natl Cancer Inst 101 2009 1244 1258
139. D.M. Hellebrekers, M.H. Lentjes, S.M. van den Bosch GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer Clin Cancer Res 15 2009 3990 3997
140. V. Melotte, M.H. Lentjes, S.M. van den Bosch N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer J Natl Cancer Inst 101 2009 916 927
141. D.A. Ahlquist, H. Zou, M. Domanico Next-generation stool DNA test accurately detects colorectal cancer and large adenomas Gastroenterology 142 2012 248 256
142. S. Ogino, K. Nosho, G.J. Kirkner A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer J Natl Cancer Inst 100 2008 1734 1738
143. K. Kawakami, A. Matsunoki, M. Kaneko Long interspersed nuclear element-1 hypomethylation is a potential biomarker for the prediction of response to oral fluoropyrimidines in microsatellite stable and CpG island methylator phenotype-negative colorectal cancer Cancer Sci 102 2011 166 174
144. C.H. Lawrie, S. Gal, H.M. Dunlop Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma Br J Haematol 141 2008 672 675
145. A. Link, F. Balaguer, Y. Shen Fecal MicroRNAs as novel biomarkers for colon cancer screening Cancer Epidemiol Biomarkers Prev 19 2010 1766 1774
146. E.K. Ng, W.W. Chong, H. Jin Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening Gut 58 2009 1375 1381
147. Z. Huang, D. Huang, S. Ni Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer Int J Cancer 127 2010 118 126
148. X.X. Pu, G.L. Huang, H.Q. Guo Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression J Gastroenterol Hepatol 25 2010 1674 1680
149. Y. Koga, M. Yasunaga, A. Takahashi MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening Cancer Prev Res (Phila) 3 2010 1435 1442
150. M. Kalimutho, B.G. Del Vecchio, C.S. Di Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer J Gastroenterol 46 2011 1391 1402
151. V. Kulda, M. Pesta, O. Topolcan Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases Cancer Genet Cytogenet 200 2010 154 160
152. H. Shibuya, H. Iinuma, R. Shimada Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer Oncology 79 2010 313 320
153. G. Nakajima, K. Hayashi, Y. Xi Non-coding microRNAs hsa-let-7g and hsa-miR-181b are associated with chemoresponse to S-1 in colon cancer Cancer Genomics Proteomics 3 2006 317 324
154. M. Svoboda, H.L. Izakovicova, R. Sefr Micro-RNAs miR125b and miR137 are frequently upregulated in response to capecitabine chemoradiotherapy of rectal cancer Int J Oncol 33 2008 541 547
155. S.B. Baylin Resistance, epigenetics and the cancer ecosystem Nat Med 17 2011 288 289
156. S.B. Baylin, P.A. Jones A decade of exploring the cancer epigenome - biological and translational implications Nat Rev Cancer 11 2011 726 734
157. M.A. Sekeres, R.V. Tiu, R. Komrokji Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes Blood 2012 Aug 22 [Epub ahead of print]
158. F. Lyko, R. Brown DNA methyltransferase inhibitors and the development of epigenetic cancer therapies J Natl Cancer Inst 97 2005 1498 1506
159. G. Garcia-Manero Demethylating agents in myeloid malignancies Curr Opin Oncol 20 2008 705 710
160. M. Dokmanovic, C. Clarke, P.A. Marks Histone deacetylase inhibitors: overview and perspectives Mol Cancer Res 5 2007 981 989
161. M. Ocker, A. Alajati, M. Ganslmayer The histone-deacetylase inhibitor SAHA potentiates proapoptotic effects of 5-fluorouracil and irinotecan in hepatoma cells J Cancer Res Clin Oncol 131 2005 385 394
162. J.C. Kim, E.S. Shin, C.W. Kim In vitro evaluation of histone deacetylase inhibitors as combination agents for colorectal cancer Anticancer Res 29 2009 3027 3034
163. J.E. Bolden, M.J. Peart, R.W. Johnstone Anticancer activities of histone deacetylase inhibitors Nat Rev Drug Discov 5 2006 769 784
164. F. Braiteh, A.O. Soriano, G. Garcia-Manero Phase I study of epigenetic modulation with 5-azacytidine and valproic acid in patients with advanced cancers Clin Cancer Res 14 2008 6296 6301
165. A. Goel, A.B. Kunnumakkara, B.B. Aggarwal Curcumin as "Curecumin": from kitchen to clinic Biochem Pharmacol 75 2008 787 809
166. A. Goel, B.B. Aggarwal Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs Nutr Cancer 62 2010 919 930
167. Y. Shen, M. Takahashi, H.M. Byun Boswellic acid induces epigenetic alterations by modulating DNA methylation in colorectal cancer cells Cancer Biol Ther 13 2012 542 552
168. W.P. Tsang, T.T. Kwok The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras Carcinogenesis 30 2009 953 959
169. G. Gabriely, T. Wurdinger, S. Kesari MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators Mol Cell Biol 28 2008 5369 5380
170. S. Zhu, M.L. Si, H. Wu MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1) J Biol Chem 282 2007 14328 14336
171. D. Sayed, S. Rane, J. Lypowy MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths Mol Biol Cell 19 2008 3272 3282
172. M. Fabbri, R. Garzon, A. Cimmino MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B Proc Natl Acad Sci U S A 104 2007 15805 15810
173. X.F. Yu, J. Zou, Z.J. Bao miR-93 suppresses proliferation and colony formation of human colon cancer stem cells World J Gastroenterol 17 2011 4711 4717
174. S.E. Jalava, A. Urbanucci, L. Latonen Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer Oncogene 2012 Jan 23 [Epub ahead of print]
175. X. Wang, E.K. Lam, J. Zhang MicroRNA-122a functions as a novel tumor suppressor downstream of adenomatous polyposis coli in gastrointestinal cancers Biochem Biophys Res Commun 387 2009 376 380
176. N. Valeri, P. Gasparini, M. Fabbri Modulation of mismatch repair and genomic stability by miR-155 Proc Natl Acad Sci U S A 107 2010 6982 6987
177. J.S. Schaefer, D. Montufar-Solis, N. Vigneswaran Selective upregulation of microRNA expression in peripheral blood leukocytes in IL-10-/- mice precedes expression in the colon J Immunol 187 2011 5834 5841
178. E. Bandres, N. Bitarte, F. Arias microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells Clin Cancer Res 15 2009 2281 2290
179. S.M. Johnson, H. Grosshans, J. Shingara RAS is regulated by the let-7 microRNA family Cell 120 2005 635 647
180. N. Raver-Shapira, E. Marciano, E. Meiri Transcriptional activation of miR-34a contributes to p53-mediated apoptosis Mol Cell 26 2007 731 743
181. A. Strillacci, C. Griffoni, P. Sansone MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells Exp Cell Res 315 2009 1439 1447
182. T. Schepeler, A. Holm, P. Halvey Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes Oncogene 31 2012 2750 2760
183. Y. Ma, P. Zhang, J. Yang Candidate microRNA biomarkers in human colorectal cancer: systematic review profiling studies and experimental validation Int J Cancer 130 2012 2077 2087
184. M. Hu, M. Xia, X. Chen MicroRNA-141 regulates Smad interacting protein 1 (SIP1) and inhibits migration and invasion of colorectal cancer cells Dig Dis Sci 55 2010 2365 2372
185. C.J. Braun, X. Zhang, I. Savelyeva p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest Cancer Res 68 2008 10094 10104
186. V. Boni, N. Bitarte, I. Cristobal miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation Mol Cancer Ther 9 2010 2265 2275
187. L. Liu, L. Chen, Y. Xu microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells Biochem Biophys Res Commun 400 2010 236 240
188. P.S. Mongroo, A.K. Rustgi The role of the miR-200 family in epithelial-mesenchymal transition Cancer Biol Ther 10 2010 219 222
189. A. Bronisz, J. Godlewski, J.A. Wallace Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320 Nat Cell Biol 14 2012 159 167
190. H. Wang, J. Wu, X. Meng MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1 Carcinogenesis 32 2011 1033 1042
191. H. Nakano, T. Miyazawa, K. Kinoshita Functional screening identifies a microRNA, miR-491 that induces apoptosis by targeting Bcl-X(L) in colorectal cancer cells Int J Cancer 127 2010 1072 1080
192. B.B. Lee, E.J. Lee, E.H. Jung Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer Clin Cancer Res 15 2009 6185 6191
193. M. Li, W.D. Chen, N. Papadopoulos Sensitive digital quantification of DNA methylation in clinical samples Nat Biotechnol 27 2009 858 863
194. H. Zou, J.J. Harrington, A.M. Shire Highly methylated genes in colorectal neoplasia: implications for screening Cancer Epidemiol Biomarkers Prev 16 2007 2686 2696
195. M. Wallner, A. Herbst, A. Behrens Methylation of serum DNA is an independent prognostic marker in colorectal cancer Clin Cancer Res 12 2006 7347 7352
196. M.P. Ebert, M. Tanzer, B. Balluff TFAP2E-DKK4 and chemoresistance in colorectal cancer N Engl J Med 366 2012 44 53
197. C.W. Wu, S.S. Ng, Y.J. Dong Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps Gut 61 2012 739 745
198. P. Akcakaya, S. Ekelund, I. Kolosenko miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer Int J Oncol 39 2011 311 318
199. R. Diaz, J. Silva, J.M. Garcia Deregulated expression of miR-106a predicts survival in human colon cancer patients Genes Chromosomes Cancer 47 2008 794 802